These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1168 related items for PubMed ID: 20887785

  • 1. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE, Kuhlmann T, Antel JP.
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [Abstract] [Full Text] [Related]

  • 2. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS, Blakemore WF.
    Adv Exp Med Biol; 1999 Feb; 468():183-97. PubMed ID: 10635029
    [Abstract] [Full Text] [Related]

  • 3. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE, Bourne JN, Evangelou AV, Khandker L, Macklin WB, Wood TL.
    J Neurosci; 2017 Aug 02; 37(31):7534-7546. PubMed ID: 28694334
    [Abstract] [Full Text] [Related]

  • 4. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA, Akirav EM.
    J Neurosci Res; 2015 May 02; 93(5):687-96. PubMed ID: 25287108
    [Abstract] [Full Text] [Related]

  • 5. The complex world of oligodendroglial differentiation inhibitors.
    Kremer D, Aktas O, Hartung HP, Küry P.
    Ann Neurol; 2011 Apr 02; 69(4):602-18. PubMed ID: 21520230
    [Abstract] [Full Text] [Related]

  • 6. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
    Wegener A, Deboux C, Bachelin C, Frah M, Kerninon C, Seilhean D, Weider M, Wegner M, Nait-Oumesmar B.
    Brain; 2015 Jan 02; 138(Pt 1):120-35. PubMed ID: 25564492
    [Abstract] [Full Text] [Related]

  • 7. Remyelination in multiple sclerosis.
    Chari DM.
    Int Rev Neurobiol; 2007 Jan 02; 79():589-620. PubMed ID: 17531860
    [Abstract] [Full Text] [Related]

  • 8. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK, Blakemore WF.
    Brain; 2005 Mar 02; 128(Pt 3):528-39. PubMed ID: 15699059
    [Abstract] [Full Text] [Related]

  • 9. The adult oligodendrocyte can participate in remyelination.
    Duncan ID, Radcliff AB, Heidari M, Kidd G, August BK, Wierenga LA.
    Proc Natl Acad Sci U S A; 2018 Dec 11; 115(50):E11807-E11816. PubMed ID: 30487224
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of remyelination: recent insight from experimental models.
    Tanaka T, Yoshida S.
    Biomol Concepts; 2014 Aug 11; 5(4):289-98. PubMed ID: 25372760
    [Abstract] [Full Text] [Related]

  • 11. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO.
    Adv Exp Med Biol; 2017 Aug 11; 958():91-127. PubMed ID: 28093710
    [Abstract] [Full Text] [Related]

  • 12. Sox2 Is Essential for Oligodendroglial Proliferation and Differentiation during Postnatal Brain Myelination and CNS Remyelination.
    Zhang S, Zhu X, Gui X, Croteau C, Song L, Xu J, Wang A, Bannerman P, Guo F.
    J Neurosci; 2018 Feb 14; 38(7):1802-1820. PubMed ID: 29335358
    [Abstract] [Full Text] [Related]

  • 13. Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
    Cui QL, Kuhlmann T, Miron VE, Leong SY, Fang J, Gris P, Kennedy TE, Almazan G, Antel J.
    Am J Pathol; 2013 Aug 14; 183(2):516-25. PubMed ID: 23746653
    [Abstract] [Full Text] [Related]

  • 14. Remyelination in multiple sclerosis.
    Lassmann H, Brück W, Lucchinetti C, Rodriguez M.
    Mult Scler; 1997 Apr 14; 3(2):133-6. PubMed ID: 9291167
    [Abstract] [Full Text] [Related]

  • 15. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
    Mei F, Mayoral SR, Nobuta H, Wang F, Desponts C, Lorrain DS, Xiao L, Green AJ, Rowitch D, Whistler J, Chan JR.
    J Neurosci; 2016 Jul 27; 36(30):7925-35. PubMed ID: 27466337
    [Abstract] [Full Text] [Related]

  • 16. Cellular approaches for stimulating CNS remyelination.
    Miller RH, Bai L.
    Regen Med; 2007 Sep 27; 2(5):817-29. PubMed ID: 17907933
    [Abstract] [Full Text] [Related]

  • 17. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, Pham-Dinh D, Levine J.
    J Neurocytol; 2002 Sep 27; 31(6-7):523-36. PubMed ID: 14501221
    [Abstract] [Full Text] [Related]

  • 18. The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis.
    Jadasz JJ, Aigner L, Rivera FJ, Küry P.
    Cell Tissue Res; 2012 Jul 27; 349(1):331-47. PubMed ID: 22322424
    [Abstract] [Full Text] [Related]

  • 19. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
    Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Zhang Y, Miklasz S, Shea D, Mason J, Franklin RJ, Ji B, Shao Z, Chédotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B.
    Ann Neurol; 2009 Mar 27; 65(3):304-15. PubMed ID: 19334062
    [Abstract] [Full Text] [Related]

  • 20. Remyelination in multiple sclerosis.
    Piaton G, Williams A, Seilhean D, Lubetzki C.
    Prog Brain Res; 2009 Mar 27; 175():453-64. PubMed ID: 19660673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.